Israeli start-up Sol-Gel Technologies recently announced an agreement with an undisclosed major U.S. pharmaceutical company to develop a dermatological product. According to a Reuters article, it’s a development and licensing...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)